The battle against major depressive disorder (MDD) continues to challenge both patients and clinicians worldwide. Current medication for major depressive disorder approaches leave approximately one-third of patients without adequate symptom relief. Fortunately, pharmaceutical innovation is accelerating, with several promising new drugs for depression entering advanced clinical development. Let’s explore seven pioneering compounds poised to transform Read.